Liu et al. reported that PIVKA-II alone achieved an AUC of 0.90 for the detection of HCC in HCV-infected patients, outperforming AFP (AUC = 0.80), while the combination of AFP and PIVKA-II further improved the diagnostic accuracy (AUC = 0.93) [26]. Here, AFP is linked to hepatocellular carcinoma.